A panel of independent advisers overseeing the Food and Drug Administration unanimously sanctioned the latest experimental drug for Alzheimer's disease on Monday, emphasizing that its benefits outweigh the associated risks.
Last Update: 2024-06-11 10:20:06 - Source: CHANNEL8